[Progressive supranuclear palsy, diagnostic problems in the light of own case]

Neurol Neurochir Pol. 1998 Nov-Dec;32(6):1513-22.
[Article in Polish]

Abstract

A case is reported in which the neurological findings and disease course meet fully the criteria of the possible progressive supranuclear palsy. The authors discuss the principles of clinical diagnosis of the syndrome, characteristic oculomotor disturbances and parkinsonian syndrome especially pronounced in this disease in the muscles of the nape, trunk and upper extremities. The main features of neuropathological changes are described fibrillary degeneration and atrophy of neurons in midbrain and pons, with accumulation of tau protein in the neurons and astrocytes in the areas involved by the process.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Astrocytes / chemistry
  • Atrophy / pathology
  • Baclofen / therapeutic use
  • Benserazide / therapeutic use
  • Brain / pathology
  • Cholinesterase Inhibitors / therapeutic use
  • Deglutition Disorders / drug therapy
  • Deglutition Disorders / etiology
  • Drug Combinations
  • Enzyme Inhibitors / therapeutic use
  • Female
  • GABA Agonists / therapeutic use
  • Humans
  • Levodopa / therapeutic use
  • Magnetic Resonance Imaging
  • Middle Aged
  • Neostigmine / therapeutic use
  • Neurons / chemistry
  • Ocular Motility Disorders / complications
  • Severity of Illness Index
  • Supranuclear Palsy, Progressive / complications
  • Supranuclear Palsy, Progressive / diagnosis*
  • Supranuclear Palsy, Progressive / drug therapy
  • tau Proteins / analysis

Substances

  • Cholinesterase Inhibitors
  • Drug Combinations
  • Enzyme Inhibitors
  • GABA Agonists
  • benserazide, levodopa drug combination
  • tau Proteins
  • Neostigmine
  • Levodopa
  • Benserazide
  • Baclofen